Abstracts
Most Viewed
Abstract
2024 ASCO Annual Meeting
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.
First Author: Peter Robert Galle
Date: Jun 4, 2024
Abstract
2022 ASCO Annual Meeting
A randomized, double-blind, phase 3 trial of MK-7684A plus chemotherapy versus pembrolizumab plus chemotherapy as first-line therapy for metastatic non–small cell lung cancer (NSCLC): KeyVibe-007.
First Author: Marina Chiara Garassino
Date: May 26, 2022
Abstract
2023 ASCO GU Cancers Symposium
Phase 3 LITESPARK-022: Pembrolizumab (pembro) plus hypoxia-inducible factor 2α (HIF-2α) inhibitor belzutifan as adjuvant treatment for clear cell renal cell carcinoma (ccRCC).
First Author: Toni K. Choueiri
Date: Feb 13, 2023
Abstract
2024 ASCO Annual Meeting
Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial.
First Author: Martijn Ruben Meijerink
Date: Jun 2, 2024
Recently Published
Abstract
2024 ASCO Quality Care Symposium
Enhancing referral practices: A bariatric department's education initiative to reduce unnecessary referrals to hematology oncology.
First Author: Jenna Synnamon
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Comparison of symptom clusters between Black and White patients with cancer within an electronic patient-reported outcome remote symptom monitoring program.
First Author: Sandra Olisakwe
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Outcomes with initiation of inpatient immunotherapy.
First Author: Jennifer Aline Marks
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Patient and care team experiences with an EHR-integrated symptom management program (eSyM) in routine oncology practice.
First Author: Christine Marie Cronin
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Cross-sectional study of assessment of lung cancer (LC) screening awareness in an underserved community in the Bronx, New York.
First Author: Nehemias Antonio Guevara Rodriguez
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Implementation of hereditary cancer risk assessment in primary care: Intervention strategies and proximal outcomes.
First Author: Sukh Makhnoon
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
The impact of neighborhood socioeconomic deprivation on clinical outcomes for locally advanced and metastatic hepatocellular carcinoma: An incidence-based retrospective cohort study.
First Author: Shreya Shah
Date: Sep 23, 2024
Abstract
2024 ASCO Quality Care Symposium
Quality improvement scorecards driving innovation and best practice in a large community oncology practice.
First Author: Molly Mendenhall
Date: Sep 23, 2024